| Description | CHST9 Human Pre-designed siRNA Set A contains three designed siRNAs for CHST9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components CHST9 siRNA-1: 5 nmol (HPLC) CHST9 siRNA-2: 5 nmol (HPLC) CHST9 siRNA-3: 5 nmol (HPLC) siRNA Negative Control:CHST9 Human Pre-designed siRNA Set A contains three designed siRNAs for CHST9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components CHST9 siRNA-1: 5 nmol (HPLC) CHST9 siRNA-2: 5 nmol (HPLC) CHST9 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | MAP kinase substrate (MBP) is a peptide substrate for ERK 1 and ERK 2 MAP kinases. Sequence contains amino acids 95-98 of myelin basic protein (MBP) including Thr 97 within the Pro-X-Ser/Thr-Pro MAP kinase substrate consensus sequence phosphorylation site.MAP kinase substrate (MBP)is a peptide MAP kinase substrate (MBP) is a peptide substrate for ERK 1 and ERK 2 MAP kinases. Sequence contains amino acids 95-98 of myelin basic protein (MBP) including Thr 97 within the Pro-X-Ser/Thr-Pro MAP kinase substrate consensus sequence phosphorylation site.MAP kinase substrate (MBP)is a peptide substrate for ERK 1 and ERK 2 MAP kinases... Read More | N-Acetylneuraminyl-fucosyllacto-N-neo-tetraose is used as a reference material in the analysis of milk oligosaccharides | Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for identification by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mainly by degradation of proteins which access the endocytic route, where they are processed by lysosomal proteases and other hydrolases... Read More |